Direct-to-consumer genetic testing is different: these genetic tests are marketed directly to customers via television, print advertisements, or the Internet, and the tests can be bought online or in stores. Customers send the company a DNA sample and receive their results directly from a secure website or in a written report. Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process. LPI (LP Information)' newest research report, the ﾓDirect-to-consumer Genetic Health Sequencing Industry Forecastﾔ looks at past sales and reviews total world Direct-to-consumer Genetic Health Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Direct-to-consumer Genetic Health Sequencing sales for 2023 through 2029. With Direct-to-consumer Genetic Health Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Direct-to-consumer Genetic Health Sequencing industry. This Insight Report provides a comprehensive analysis of the global Direct-to-consumer Genetic Health Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Direct-to-consumer Genetic Health Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsﾒ unique position in an accelerating global Direct-to-consumer Genetic Health Sequencing market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Direct-to-consumer Genetic Health Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Direct-to-consumer Genetic Health Sequencing. The global Direct-to-consumer Genetic Health Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Direct-to-consumer Genetic Health Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Direct-to-consumer Genetic Health Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Direct-to-consumer Genetic Health Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Direct-to-consumer Genetic Health Sequencing players cover 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center and Invitae, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Direct-to-consumer Genetic Health Sequencing market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Diagnostic Screening PGD Relationship Testing Segmentation by application Online Offline This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. 23andMe MyHeritage LabCorp Myriad Genetics Ancestry.com Quest Diagnostics Gene By Gene DNA Diagnostics Center Invitae IntelliGenetics Ambry Genetics Living DNA EasyDNA Pathway Genomics Centrillion Technology Xcode Color Genomics Anglia DNA Services African Ancestry Canadian DNA Services DNA Family Check Alpha Biolaboratories Test Me DNA 23 Mofang Genetic Health DNA Services of America Shuwen Health Sciences Mapmygenome Full Genomes
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Direct-to-consumer Genetic Health Sequencing Market Size 20
